Electrochemotherapy on Head and Neck Cancer

Summary

A phase II clinical trial testing electrochemotherapy on mucosal recurrent head and neck cancer. Twenty-five patients will be treated. Primary outcome is tumour response on imaging. Secondary outcomes are response from tissue samples, VAS score, Quality of life evaluation and side effects to treatment.

Timeline

Start

2014-02

Primary completion

2019-09

Completion

2019-09

Drugs

Indications